Skip to main content
. 2024 Oct 18;25:364. doi: 10.1186/s12882-024-03798-2

Fig. 4.

Fig. 4

Pathways enriched by Enrichr analysis (with an adjusted p-value < 0.05, corresponding to differentially expressed genes (DEGs) in CKD, listed in Fig. 3). (a-b) Downregulated pathways in CKD derived from DEGs in the glomerular and tubular areas compared with controls, detected in the C-PROBE cohort of CKD (a) and Susztak’s group of DN (b). (c-d) Similar analysis for upregulated pathways